Predictions
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.96
01.12.21
01.12.21
€6.00
01.12.22
01.12.22
-2.70%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.91
01.12.21
01.12.21
-
01.12.22
01.12.22
-1.46%
11.12.21
11.12.21
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.00
28.11.21
28.11.21
-
28.11.22
28.11.22
7.65%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.50
22.11.21
22.11.21
-
22.11.22
22.11.22
-2.83%
28.11.21
28.11.21
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.37
22.11.21
22.11.21
-
22.11.22
22.11.22
-20.45%
27.11.21
27.11.21
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.97
15.11.21
15.11.21
-
15.11.22
15.11.22
-28.16%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.03
11.11.21
11.11.21
€2.90
11.11.22
11.11.22
-21.78%
28.04.22
28.04.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.17
03.11.21
03.11.21
-
03.11.22
03.11.22
-8.41%
15.11.21
15.11.21
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.86
27.10.21
27.10.21
€40.00
31.12.23
31.12.23
-59.32%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.01
25.10.21
25.10.21
-
25.10.22
25.10.22
-1.37%
31.10.21
31.10.21
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.49
10.10.21
10.10.21
€5.00
31.12.23
31.12.23
-32.83%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.00
05.10.21
05.10.21
-
05.10.22
05.10.22
-10.00%
08.12.21
08.12.21
Probably not worthwhile Investment
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.40
04.10.21
04.10.21
-
04.10.22
04.10.22
45.45%
10.08.22
10.08.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.92
28.09.21
28.09.21
-
28.09.22
28.09.22
-6.85%
02.10.21
02.10.21
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.20
18.09.21
18.09.21
€40.00
31.12.23
31.12.23
61.97%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.96
25.08.21
25.08.21
-
25.08.22
25.08.22
4.84%
05.09.21
05.09.21
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.83
17.08.21
17.08.21
-
17.08.22
17.08.22
-9.02%
22.08.21
22.08.21
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.95
05.08.21
05.08.21
-
05.08.22
05.08.22
23.44%
08.08.21
08.08.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.71
15.07.21
15.07.21
-
15.07.22
15.07.22
1.92%
23.04.22
23.04.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.45
10.07.21
10.07.21
€1.90
10.07.22
10.07.22
23.96%
11.11.21
11.11.21
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
08.07.21
08.07.21
-
08.07.22
08.07.22
13.98%
08.07.22
08.07.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.23
28.06.21
28.06.21
-
28.06.22
28.06.22
-24.89%
29.06.22
29.06.22